Skip to main content
Clinical Trials/NCT05107830
NCT05107830
Unknown
Not Applicable

Phenotyping of Primary Hyperoxaluria in Children and Adults

University Hospital, Strasbourg, France1 site in 1 country186 target enrollmentJanuary 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Hyperoxaluria
Sponsor
University Hospital, Strasbourg, France
Enrollment
186
Locations
1
Primary Endpoint
Retropsective study of classic presentations of atypical presentations of primitive hyperoxaluria and its characteristics of atypical presentations
Last Updated
4 years ago

Overview

Brief Summary

985 / 5000 Résultats de traduction Primary hyperoxaluria is a rare autosomal recessive disease with an estimated prevalence of around 1 to 3 cases per million population. The most frequent attacks are urolithiasis disease and nephrocalcinosis, ultimately leading to end-stage chronic renal failure. The phenotype of this pathology is very heterogeneous, making the diagnosis difficult.

There is currently a significant diagnostic delay. This is potentially due to atypical forms, or to insufficient clinicians' awareness of its research.

However, the early diagnosis of this pathology is essential, since end-stage chronic renal failure can be avoided or at least delayed with early and appropriate management.

The objective of the study is to describe the phenotype of currently diagnosed primary hyperoxaluria, in order to identify the classic presentations but also the characteristics of atypical presentations

Registry
clinicaltrials.gov
Start Date
January 22, 2021
End Date
January 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retropsective study of classic presentations of atypical presentations of primitive hyperoxaluria and its characteristics of atypical presentations

Time Frame: Files analysed retrospectively from January 01, 2015 to December 31, 2019 will be examined]

Study Sites (1)

Loading locations...

Similar Trials